NYSE:WST - West Pharmaceutical Services Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $99.41 +1.40 (+1.43 %) (As of 07/19/2018 12:49 PM ET)Previous Close$98.23Today's Range$98.23 - $99.4352-Week Range$80.02 - $103.36Volume5,001 shsAverage Volume358,816 shsMarket Capitalization$7.27 billionP/E Ratio35.26Dividend Yield0.57%Beta1.12 Company ProfileFinancialsAnalyst RatingsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. Receive WST News and Ratings via Email Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Fabricated rubber products, not elsewhere classified Sub-IndustryHealth Care Supplies SectorMedical SymbolNYSE:WST CUSIP95530610 Webwww.westpharma.com Phone610-594-2900 Debt Debt-to-Equity Ratio0.15 Current Ratio2.82 Quick Ratio2.00 Price-To-Earnings Trailing P/E Ratio35.26 Forward P/E Ratio35.38 P/E Growth3.2 Sales & Book Value Annual Sales$1.60 billion Price / Sales4.57 Cash Flow$4.1612 per share Price / Cash23.89 Book Value$17.24 per share Price / Book5.77 Profitability EPS (Most Recent Fiscal Year)$2.78 Net Income$150.70 million Net Margins8.20% Return on Equity14.40% Return on Assets9.87% Miscellaneous Employees7,500 Outstanding Shares73,580,000Market Cap$7,274.65 West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions What is West Pharmaceutical Services' stock symbol? West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST." How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services? West Pharmaceutical Services announced a quarterly dividend on Friday, May 4th. Shareholders of record on Wednesday, July 18th will be given a dividend of $0.14 per share on Wednesday, August 1st. This represents a $0.56 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 17th. View West Pharmaceutical Services' Dividend History. How will West Pharmaceutical Services' stock buyback program work? West Pharmaceutical Services announced that its Board of Directors has approved a share buyback program on Thursday, February 15th 2018, which permits the company to buyback 800,000 shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its stock is undervalued. How were West Pharmaceutical Services' earnings last quarter? West Pharmaceutical Services Inc. (NYSE:WST) released its earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.62 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.64 by $0.02. The medical instruments supplier had revenue of $415.70 million for the quarter, compared to the consensus estimate of $403.87 million. West Pharmaceutical Services had a return on equity of 14.40% and a net margin of 8.20%. West Pharmaceutical Services's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.60 earnings per share. View West Pharmaceutical Services' Earnings History. When is West Pharmaceutical Services' next earnings date? West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for West Pharmaceutical Services. What guidance has West Pharmaceutical Services issued on next quarter's earnings? West Pharmaceutical Services updated its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share (EPS) guidance of $2.80 to $2.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.82. The company issued revenue guidance of $1.72 billion to $1.73 billion, compared to the consensus revenue estimate of $1.72 billion. What price target have analysts set for WST? 5 brokerages have issued 1-year price targets for West Pharmaceutical Services' shares. Their predictions range from $85.00 to $115.00. On average, they expect West Pharmaceutical Services' stock price to reach $104.20 in the next year. This suggests a possible upside of 4.8% from the stock's current price. View Analyst Ratings for West Pharmaceutical Services. What is the consensus analysts' recommendation for West Pharmaceutical Services? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." Who are some of West Pharmaceutical Services' key competitors? Some companies that are related to West Pharmaceutical Services include Eisai (ESALY), OTSUKA HOLDINGS/ADR (OTSKY), Centene (CNC), Amadeus It Group (AMS), McKesson (MCK), Fresenius Medical Care AG & Co. KGaA (FME), Essilor International Cmgn Gnl D Optq (EI), Teva Pharmaceutical Industries (TEVA), Zimmer Biomet (ZBH), TERUMO Corp/ADR (TRUMY), LONZA Grp AG/ADR (LZAGY), IDEXX Laboratories (IDXX), COLOPLAST A/S/ADR (CLPBY), Cerner (CERN) and Sunny Optical Technology (Group) (SNPTF). Who are West Pharmaceutical Services' key executives? West Pharmaceutical Services' management team includes the folowing people: Mr. Eric M. Green, CEO, Pres & Director (Age 48)Mr. William J. Federici, CFO, Sr. VP & Treasurer (Age 58)Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 63)Ms. Annette F. Favorite, Chief HR Officer and Sr. VP (Age 53)Ms. Karen A. Flynn, Chief Commercial Officer and Sr. VP (Age 55) Has West Pharmaceutical Services been receiving favorable news coverage? News articles about WST stock have trended somewhat negative recently, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. West Pharmaceutical Services earned a news impact score of -0.02 on Accern's scale. They also gave media headlines about the medical instruments supplier an impact score of 44.75 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days. Who are West Pharmaceutical Services' major shareholders? West Pharmaceutical Services' stock is owned by a number of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (1.33%), Riverbridge Partners LLC (0.64%), Retirement Systems of Alabama (0.17%), Nisa Investment Advisors LLC (0.10%), Amalgamated Bank (0.02%) and Xact Kapitalforvaltning AB (0.02%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner, Paula A Johnson and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services. Which institutional investors are selling West Pharmaceutical Services stock? WST stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Retirement Systems of Alabama, Fisher Asset Management LLC, Oakbrook Investments LLC, Amalgamated Bank and World Asset Management Inc. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Daniel Malone and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services. Which institutional investors are buying West Pharmaceutical Services stock? WST stock was acquired by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Bank of Montreal Can, Xact Kapitalforvaltning AB and State of Alaska Department of Revenue. View Insider Buying and Selling for West Pharmaceutical Services. How do I buy shares of West Pharmaceutical Services? Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is West Pharmaceutical Services' stock price today? One share of WST stock can currently be purchased for approximately $99.41. How big of a company is West Pharmaceutical Services? West Pharmaceutical Services has a market capitalization of $7.27 billion and generates $1.60 billion in revenue each year. The medical instruments supplier earns $150.70 million in net income (profit) each year or $2.78 on an earnings per share basis. West Pharmaceutical Services employs 7,500 workers across the globe. How can I contact West Pharmaceutical Services? West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected] MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)Community Ranking: 1.8 out of 5 ()Outperform Votes: 140 (Vote Outperform)Underperform Votes: 259 (Vote Underperform)Total Votes: 399MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/19/2018 by MarketBeat.com StaffFeatured Article: Should I invest in "strong buy" stocks?